BASF strengthens its Agricultural Products business
"This acquisition allows us to considerably enhance our insecticide business, especially in growing and attractive specialty markets. The seed treatment business is also a very good fit with our new fungicides which have excellent potential in this market," said Peter Oakley, member of BASF's Board of Executive Directors and responsible for the Agricultural Products & Nutrition segment.
The total package with sales of EUR500 million in 2001 is valued at EUR1,330 million. Taking into consideration back-licenses granted by BASF to Bayer CropScience for selected non-agricultural uses, the purchase price amounts to EUR1,185 million.
Fipronil is a broad-spectrum insecticide from the new insecticide chemistry class of phenyl pyrazoles. It has an excellent activity against many major insect pests in crop and non-crop markets. The most important uses are soil application and seed treatment in crop and termite control in non-crop markets. Fipronil is currently registered and sold in over 70 countries. The fungicides included in the acquisition are triticonazole, iprodione, prochloraz, pyrimethanil and fluquinconazole for certain uses and regions.
The manufacturing facilities for fipronil, triticonazole, and iprodione, located at Elbeuf, France, and employing about 340 persons are also part of the transaction.
"With this acquisition we close a strategic gap in our insecticides portfolio, strengthen our position in growing market segments, such as seed treatment and non-crop uses, and create market synergies with our current portfolio," says Hans W. Reiners, head of BASF's Agricultural Products division. "BASF's strong commercial presence in all major markets will enable us to rapidly integrate and fully realize the potential value of these products."
While conditions in the agricultural markets continue to be challenging, Reiners sees a promising future for BASF in this market: "With the acquired products and our new market introductions, we have a strong foundation for growth. This is an important step towards achieving our mid-term goal of a 25 percent EBITDA margin."
Most read news
Other news from the department business & finance
Get the chemical industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.